DGAP-News: Heliad Equity Partners GmbH & Co. KGaA
/ Key word(s): Disposal
Frankfurt am Main, 23 January 2020 - Heliad Equity Partners GmbH & Co. KGaA (ISIN: DE000A0L1NN5) announces that it has sold all of its shares in AlphaPet Ventures GmbH as part of a secondary transaction.
The sale is in connection with the investment into AlphaPet from private equity investor capiton and the acquisition of Healthfood24 GmbH with the "Wolfsblut" brand. Capiton is financing this acquisition as the new lead investor of AlphaPet.
Heliad expects the sale of its shares to generate a liquidity inflow of around EUR 4.0 million in the first quarter of 2020. The sale will have a positive impact on HGB earnings in the current year.
The acquisition is still subject to approval by the Federal Cartel Office, which in turn is also a condition precedent for Heliad's secondary transaction.
23.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Company:||Heliad Equity Partners GmbH & Co. KGaA|
|60322 Frankfurt am Main|
|Phone:||+49 69 71 91 59 65 0|
|Fax:||+49 69 71 91 59 65 11|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||959461|
|End of News||DGAP News Service|